Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: Eur J Clin Pharmacol. 2007 Dec 19;64(2):207–216. doi: 10.1007/s00228-007-0427-9

Fig. 8.

Fig. 8

ELLDOPA design showing natural history and alternative predictions for levodopa. The lowest curve shows levodopa symptomatic and protective actions, the middle curve shows levodopa symptomatic action alone, the upper curve is the natural history progression curve